INS and type 1 diabetes mellitus: Another limitation of our study is not having analyzed the time in tight range, (the time when glucose readings are within 70–140 mg/dL or 3.9–7.8 mmol/L), which is an emerging variable as an informed measure of time in range, particularly for individuals with type 1 diabetes using automated insulin delivery systems or individuals with type 2 diabetes using glucose-lowering agents [13].